Penn Medicine Provider
Dermatology
Nicholas Kian Mollanazar, MD, MBA
he/him/his
4.5
(1413)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman

About me

  • Co-Chair, Electronic Medical Record Governance, Department of Dermatology
  • Director, Dermatology Patient Access
  • Applied Informatics Specialist, Dermatology
  • Assistant Professor of Clinical Dermatology

Education and training

  • Medical School: Temple University
  • Residency: Pennsylvania Hospital
  • Residency: Temple University Hospital

What my patients think about me

Average Rating
4.5

1416 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
conscientious and efficient
June 2025
5.0
5.0
was thorough and answered all questions
June 2025
5.0
5.0
nice service
June 2025
5.0
5.0
everything was efficient and quick and no pain

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Mollanazar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Kwatra SG, Yosipovitch G, Mollanazar NK, Stander S, Kim BS, Hong HC, Msihid J, Bansal A, O'Malley TJ, Bahloul D, Thomas RB Dupilumab Improves Multiple Factors Impacting Quaility of Life in Adults With Prurigo Nodulras (LIBERTY-PN PRIME and PRIME2) , CDA Annual Conference: 2023


Yosipovitch G, Mollanazar NK, Stander S, Kwatra SG, Kim BS, Laws E, Mannent LP, Amin N, Akinlade, Staudinger H, Patel N, Yancopoulos GD, Weinreich DM, Wang S, Shi G, Bansal A, O'Malley JT Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials , Nat Med, 29(5): 2023,1180-90


Florez A, Yosipovitch G, Kwatra SG, Mollanazar N, Stander S Satoh T, Laws E, Mannent LP, Mortensen E, Maloney J, Shi G, Bansal, Martincova R Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From Two Phase 3 Trails (LIBERTY-PN PRIME and PRIME 2) , Academia Espnola de Dermatologia y Venereologia (AEDV): 2023


Kwatra SG, Yosipovitch G, Mollanazar NK, Stander S, Kim BS, Msihid J, Bansal A, O'Malley TJ, Bahloul D, Thomas RB Dupilumab Improves Multiple Factors Impacting Quaility of Life in Adults With Prurigo Nodulras (LIBERTY-PN PRIME and PRIME2) , American Academy of Dermatology Annual Meeting: 2023


Sow Y, Wachuku C, Barrera T, Jackson T, Ayoade KO, Taylor SC, Mollanazar NK Palmer and Plantar Erythema: An Initial Presentation of Undifferentiated Connective Tissue Disease , JAAD Case Reports, 35: 2023,94-97


Wachuku C, Barrera T, Jackson T, Sow Y, Mollanazar NK, Taylor SC Upadacitinib, after failure with Dupilumab, as a treatment for chronic pruritus secondary to Polycythemia Vera , JAAD Case Rep, 35: 2023,87-89


Yosipovitch G, Mollanazar NK, Stander S, Kwatra SG, Kim BS, Laws E, Mannent LP, Amin N, Akinlade B, Wang S, Shi G, Patel K, Bansal A, O'Malley TJ Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From a 2nd Phase 3 Trail (LIBERTY-PN PRIME) , Hawaii Dermatology Seminar: 2023


Yosipovitch G, Kwatra SG, Mollanazar N, Stander S Satoh T, Laws E, Mannent LP, Mortensen E, Maloney J, Shi G, Bansal A, Martincova R Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From a 2nd Phase 3 Trails (LIBERTY-PN PRIME and PRIME2) , 4th San Diego Dermatology Symposium: 2023


Yosipovitch G, Kwatra SG, Mollanazar NK, Stander S Satoh T, Laws E, Mannent LP, Mortensen E, Maloney J, Shi G, Bansal E, Martincova R Dupilumab Significantly Improves Itch and Skin Lesions in Patients With Prurigo Nodulras: Pooled Results From Two Phase 3 Trails (LIBERTY-PN PRIME and PRIME 2) , Maui Derm Conference: 2023


Omar D, Brown-Korsah JB, Taylor SC, Mollanzar NK Automated Pharmacy substitution for medications not covered by medicaid: A model for reducing the burden of prior authorizations in dermatology , J AM Acad Dermatol, 88(1): 2023,258-60


View all publications